PROLONG Prospective, Multi-center, Open-label, Post-market Study (PROLONG)
ClinicalTrials.gov NCT03908476
Research payments
$152,923
Through program year 2020, $152,923 in research payments was reported against PROLONG Prospective, Multi-center, Open-label, Post-market Study (PROLONG), across 122 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- NCT03908476
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $152,923 | 122 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Richard Paicius Irvine, CA Named on 9 payments
- David Schultz Maple Grove, MN Named on 9 payments
- Nestor Tomycz Washington, PA Named on 8 payments
- Jason Pope Santa Rosa, CA Named on 8 payments
- Timothy Deer Charleston, WV Named on 7 payments
- Nathan Miller Denver, CO Named on 7 payments
- Fotios Vrionis Boca Raton, FL Named on 7 payments
- Anthony Hadden Bend, OR Named on 7 payments
- Brian Joves Sacramento, CA Named on 7 payments
- Corey Hunter New York, NY Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.